ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BVXP Bioventix Plc

4,375.00
25.00 (0.57%)
21 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Bioventix Plc LSE:BVXP London Ordinary Share GB00B4QVDF07 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  25.00 0.57% 4,375.00 4,300.00 4,450.00 4,375.00 4,375.00 4,375.00 1,477 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 12.82M 8.37M 1.6071 27.22 227.91M
Bioventix Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker BVXP. The last closing price for Bioventix was 4,350p. Over the last year, Bioventix shares have traded in a share price range of 3,450.00p to 5,060.00p.

Bioventix currently has 5,209,333 shares in issue. The market capitalisation of Bioventix is £227.91 million. Bioventix has a price to earnings ratio (PE ratio) of 27.22.

Bioventix Share Discussion Threads

Showing 1 to 19 of 1575 messages
Chat Pages: Latest  3  2  1
DateSubjectAuthorDiscuss
18/12/2013
18:08
An odd announcement. Kim Tan leaves the board with no explanation and no notice (at least, none to shareholders that I know of).
Nigel Martin

gnnmartin
04/10/2013
11:36
Now the results data has been updated for BVXP on Stocko pedia, it is today appearing on the Philip Fisher Growth Screen, which requires a stock to have:

A 5yr CAGR > median
Sales growth streak (3 yrs consecutive growth)
Net margin > median
PEG < 0.5

hxxp://www.stock opedia.co.uk/checklists/philip-fisher-growth-screen-94/?ticker=OFEX:BVXP

Now for Peter to get out there and tell the story, and help liquidity in the stock pick up.

strollingmolby
01/10/2013
10:29
Possible meeting with CEO Peter Harrison this afternoon in London West End at 4pm. If you would like to attend please email leon@boros.co.uk
boros10
26/9/2013
23:45
A very strong performance in H2 - real momentum developing now from royalties linked to the Vitamin D anti-bodies with further growth expected. All positive, however, as revenues become increasingly skewed to royalties linked to the product sales of its customers which the Company only discovers after the period end - the visibility of earnings is declining and debtors are starting to rise.

The Company also has no real way of checking whether its customers are being honest when they report sales. This might limit growth in countries like China not known for tranparency which might be the reason why anti-body sales are growing but royalties still lag in the people's republic.

Overall, shareholders should be delighted though. Peter Harrison, CEO continues to deliver on his promises and we should see 20% compound earnings growth for some years to come.

A strong buy even after today's big increase but you won't find it easy to get hold of any stock!

boros10
26/9/2013
21:59
I've updated the six-month segment data for EPS and dividends in the header, and this is showing a very solid growth trend.

Annualised it looks like this:
2011 2012 2013 2-yr change
Revenue (£k) 1,974 2,384 2,706 +37.1%
Net profit (£k) 884 1,237 1,521 +72.1%
EPS (p) 17.59p 24.62p 30.28p +72.1%
Working cap (£k) 2,185 2,874 3,764 +72.3%
Dividend 11p 12.1p 14.57p +32.5%
Cash (£k) 1,532 2,179 2,586 +68.8%

And with an operating margin of 56%.

Springhill must be kicking themselves...

strollingmolby
26/9/2013
16:27
Bioventix - Preliminary audited results for the year ended 30 June 2013

Click the link to listen

sammy_smith
26/9/2013
13:06
Yes, agreed, Nigel - very solid results!

PS just noticed on my Bloomberg app, the share price has shot up - seems someone has just paid 450p...

Latest Trades

26/09/2013 12:24 500 @ 450
26/09/2013 11:12 1,000 @ 385
26/09/2013 11:12 1,000 @ 385
26/09/2013 11:06 1,000 @ 380
26/09/2013 11:05 1,000 @ 355
26/09/2013 11:00 1,000 @ 350
26/09/2013 09:13 1,000 @ 345

strollingmolby
26/9/2013
10:48
Very satisfactory full year results:
* Revenues have grown by 14% compared with the year to 30 June 2012
* Profit after tax increased by 23% compared with the year to 30 June 2012
* Cash balances of GBP2.585m at 30 June 2013 (GBP2.179m at 30 June 2012)
* Dividend declared of 8.77p (2012: 7.26p)
plus
"The continued excellent performance of the company in a globally competitive
market for antibodies is very satisfying.
A PE of 11.5 at 345p, plus a dividend yield of about 4.5% and good growth prospects.
Nigel Martin
PS. StrollingMolby you were impressively quick to update the header!

gnnmartin
07/9/2013
14:15
I make the PEG to be 0.13 taking the average of the last 5 years EPS growth as a guide for next years growth
99matti99
21/8/2013
16:13
Qualifies for ISA under new rules. I put some in mine today.

From the ISDX site:

'ISA eligibility consultation:
Following recent amendments by the Government to the ISA Regulations 1998 which came into force on 5 August 2013, ISDX is delighted to confirm that shares admitted to trading on its ISDX Growth Market (a Recognised Stock Exchange) are now qualifying investments for stocks and shares ISAs.'

I need to do a bit more research but like what i see so far (obviously, just bought some!). Appears to be in the same game as Abcam (LSE:ABC) which is now just short of a billion pound company. Can comparisons be drawn?

And then there were 3.........;-)

99matti99
11/7/2013
12:40
Confirmation of SpringHill's exit last week:

SHAREHOLDER NOTIFICATION

11 JULY 2013

The Company has received notification that SpringHill Bioventures Sdn Bhd
("SpringHill") sold 2,295,000 ordinary shares in Bioventix plc on 28 June 2013.
As a result SpringHill has ceased to be a shareholder in Bioventix plc.

strollingmolby
03/7/2013
23:08
Thanks, now I see the large trade/s on the ISDX page (would have liked to participate at 260p) - didn't see it earlier. My mistake on the 600k+ volume on this site, had misread it as '000s when in fact the ISDX page shows 625 shares...

Its a shame ADVFN have messed up the site for non-premium users, and don't currently allow them to tailor their threads - if this changes in future I'll work on the header and bring a graph and other details in.

strollingmolby
03/7/2013
21:06
Sorry, I didn't realise you were talking about he trade reports. The large one from Friday appears on the ISDX page - not sure why there are two similar sizes - probably just to stages in the deal.

Where do you see the 600k trade?

briangeeee
03/7/2013
20:02
Well spotted, I can't see the 2,295,000 share volume yet. (I can see >600k yesterday)

Should see BVXP drop off SpringHill's investee company list in due course if so hxxp://www.springhilluk.com/investee_companies.html

strollingmolby
03/7/2013
19:49
I'm just assuming they sold fully because the reported size matched their holding.

Last Friday's trade was, I think, prepared over a few weeks. A friend let me know early last week, so a few of us participated in non-notifiable sizes. Apart from Springhill themselves, there may be other large holders yet to report.

It's positive for the company that the Springhill overhang is now clear without being dripped into the market, and hopefully it will generate a little more liquidity in future.

briangeeee
03/7/2013
19:06
Hi Brian - good to see I'm not talking to myself here! Where did you hear about the Friday trade?
strollingmolby
03/7/2013
19:04
I think Springhill sold out completely on Friday. There must be some more announcements to come.
briangeeee
03/7/2013
17:34
Henderson Global Investors appear on the register today with 26.76% - does this contain the holding that Miton manage in the Henderson Fledgling trust, or has HGI bought from SpringHill....?? Hmmmm...
strollingmolby
26/3/2013
15:16
Just made a maiden purchase in these, which was bloody difficult!

The interims are due to be released this week - will be interesting to see the progress against the prior year comparables as well as H2 to Jun-12.

strollingmolby
Chat Pages: Latest  3  2  1